Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Wegovy
Wegovy
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Reuters
Wegovy
Novo Nordisk
weight loss
patient adherence
Flag link:
As Ozempic cases mount, consumer lawyers push to consolidate lawsuits
As Ozempic cases mount, consumer lawyers push to consolidate lawsuits
Reuters
legal
weight loss
Ozempic
Wegovy
Novo Nordisk
side effects
Flag link:
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Reuters
Novo Nordisk
obesity
physicians
Wegovy
Ozempic
Flag link:
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Reuters
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
Flag link:
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
BioPharma Dive
Biohaven
weightloss
Ozempic
Wegovy
Flag link:
The Next Generation of Weight Loss Drugs is Rapidly Approaching
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Flag link:
Novo Nordisk offers staff free Wegovy
Novo Nordisk offers staff free Wegovy
Beckers Hospital Review
Novo Nordisk
Wegovy
employee benefits
Flag link:
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Flag link:
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
Flag link:
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Flag link:
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Flag link:
Senator floats new models to manage costs of weight loss drugs like Ozempic
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
Flag link:
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Motley Fool
Novo Nordisk
Wegovy
weightloss
Flag link:
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Novo Nordisk
Eli Lilly
Wegovy
Mounjaro
weightlosss
Flag link:
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Stat
Novo Nordisk
Wegovy
osteoarthritis
Flag link:
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Stat
Pfizer
danuglipron
obesity
Wegovy
Mounjaro
Novo Nordisk
Flag link:
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Flag link:
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
Fierce Pharma
Novo Nordisk
Ozempic
Wegovy
Flag link:
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Forbes
weight loss
Ozempic
Wegovy
Novo Nordisk
Eli Lilly
Mounjaro
Flag link:
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
CP Wire/Businesswire
weight loss
patients
physicians
Sermo
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Flag link:
Pages
1
2
3
4
5
next ›
last »